(Q51558692)

English

Hypertension and its treatment influence changes in fasting nonesterified fatty acid concentrations: a link between the sympathetic nervous system and the metabolic syndrome?

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10647068

Hypertension and its treatment influence changes in fasting nonesterified fatty acid concentrations: a link between the sympathetic nervous system and the metabolic syndrome? (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10647068

arterial hypertension

0 references

0 references

metabolic syndrome

1 reference

based on heuristic

inferred from title

Christopher D Byrne

2

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10647068

Nicholas J. Wareham

4

object named as

Wareham NJ

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

author name string

Maison P

1

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10647068

Hales CN

3

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10647068

publication date

1 January 2000

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10647068

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10647068

49

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10647068

1

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10647068

81-87

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10647068

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2990788-1

7 January 2021

Insulin resistance in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2990788-1

7 January 2021

Insulin resistance and blood pressure in young black men.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2990788-1

7 January 2021

The hemodynamic link between insulin resistance and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2990788-1

7 January 2021

Hypertension and hyperinsulinaemia: a relation in diabetes but not essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2990788-1

7 January 2021

Obesity hypertension is related more to insulin's fatty acid than glucose action.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2990788-1

7 January 2021

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2990788-1

7 January 2021

The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2990788-1

7 January 2021

Decreased non-esterified fatty acid suppression and features of the insulin resistance syndrome occur in a sub-group of individuals with normal glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2990788-1

7 January 2021

Hypertriglyceridaemia in subjects with normal and abnormal glucose tolerance: relative contributions of insulin secretion, insulin resistance and suppression of plasma non-esterified fatty acids.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2990788-1

7 January 2021

The effect of propranolol on free fatty acid mobilization and resting metabolic rate

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2990788-1

7 January 2021

Fatty acids enhance vascular alpha-adrenergic sensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2990788-1

7 January 2021

Obesity, the sympathetic nervous system, and essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2990788-1

7 January 2021

Undiagnosed glucose intolerance in the community: the Isle of Ely Diabetes Project

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2990788-1

7 January 2021

Fasting proinsulin concentrations predict the development of type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2990788-1

7 January 2021

Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2990788-1

7 January 2021

Enzymatic determination of serum-free fatty acids: a colorimetric method

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2990788-1

7 January 2021

Adrenergic mechanisms in control of plasma lipid concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2990788-1

7 January 2021

Metabolic effects of pindolol and propranolol in a double-blind cross-over study in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2990788-1

7 January 2021

Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2990788-1

7 January 2021

Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2990788-1

7 January 2021

Role of the sympathetic nervous system in blood pressure maintenance in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2990788-1

7 January 2021

Determination of beta 3-adrenoceptor mediated lipolysis in human fat cells

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2990788-1

7 January 2021

Clinical pharmacology of beta 3-adrenoceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2990788-1

7 January 2021

Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2990788-1

7 January 2021

Comparison of effects on lipid metabolism of antihypertensive drugs with alpha- and beta-adrenergic antagonist properties

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2990788-1

7 January 2021

Hydrochlorothiazide-induced sympathetic hyperactivity in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2990788-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0026-0495(00)90788-1

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10647068

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10647068

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51558692&oldid=1609929148"